1997-2000 - MMS

Go to content

Main menu:


51. P.G. Baraldi, B. Cacciari, S. Moro, R. Romagnoli, G. Spalluto, K.N. Klotz, E. Leung, K. Varani, S. Gessi, S. Merighi, P.A. Borea “Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen. J Med. Chem. 43, 4768-4780 (2000)

50. E. Nandanan, S.-Y- Jang, S. Moro, H. Kim, M. A. Siddiqui, P. Russ, V. E. Marquez, R. Busson, P. Herdewijn, K. Harden, J. L. Boyer, K. J. Jacobson “Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y1 receptor ligands”. J Med. Chem. 43, 829-842 (2000)

49. I. Menegazzo, S. Moro, G. Sandonà, V. Sheeba, G. ZagottoP P“A versatile synthesis of the 1,4-dihydroxynaphthoquinone nucleus”. Tetrahedron Lett. 31, 6631-6634 (2000)

48. V. Cecchetti, S. Moro, C. Parolin, T. Pecere, E. Filipponi, A. Calistri, O. Tabarrini, B. Gatto, M. Palumbo, A. Fravolini, G. Palù “6-amino quinolones as new potential anti-HIV agents.” J. Med. Chem. 43, 3799-802. (2000)

47. G. Viola, E. Uriarte, S. Moro “Interactions between DNA and benzopsoralen analogues: thermodynamic and molecular modeling studies.” Farmaco 55, 276-86 (2000)

46. O. Bortolini, M. Carraro, V. Conte, S. Moro, “Models for the active site of vanadium dependent haloperoxidases: insight into the solution structure of peroxo vanadium compounds.” J. Bioinorg. Chem. 80, 41-49 (2000)

45. G. Zagotto, S. Moro, R. Supino, E. Favini, M.Palumbo “New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.” Farmaco 55, 1-5 (2000)

44. E. Soldaini, S. Moro, S. John, J. Bollenbacher, U. Schindler, W.J. Leonard “Dna binding site selection of dimeric and tetrameric Stat5 proteins reveals a large repertoire of divergent tetrameric Stat5a binding sites.” Mol. Cell. Biol. 20, 389-401 (2000)

43. G.G. Aloisi, F. Elisei, S. Moro, D. Vedaldi, F. Dall’Acqua “Photophysical behavior of thio- and seleno-psoralens.” Photochem. Photobiol. 71, 506-513 (2000)

42. O. Bortolini, M. Carraro, V. Conte, S. Moro “Histidine containing diperoxovanadium (V) compounds: insight on the solution structure by a 51V-NMR and ESI-MS comparative study.” Eur. J. Inorg. Chem. 9, 1489-1495 (1999)

41. S. Moro, M. Bonchio, G. Licini, G. Modena, O. Bortolini, W. A. Nugent “Enantioselective Ti(IV) sulfoxidation catalysts bearing C3-symmetric trialkanolamine ligands: solution speciation by 1H NMR and ESI-MS analysis.” J. Am. Chem Soc. 121, 6258-6268 (1999)

40. J.-l. Jiang, S. Moro, A.H. Li, S.-Y. Jang, L. Chang, N. Melman, X.D. Ji, E.B. Lobkovsky, J.C. Clardy, K.A. Jacobson “Chiral resolution and stereospecificity of 4-phenylethynyl-6-phenyl-1,4-dihydropyridines as selective AB3B adenosine receptor antagonists.” J. Med. Chem. 42, 3055-3065 (1999)

39.     G. Miolo, S. Moro, D. Vedaldi, S. Caffieri, A. Guiotto, F. Dall’Acqua “New benzoquinolizin-5-one derivatives as furocoumarin analogs: DNA-interactions and molecular modeling studies.” Farmaco. 54, 551-61 (1999)

38. C. Hoffmann, S. Moro, R.A. Nicholas, T.K. Harden, K.A. Jacobson “The role of amino acids in entracellular loops of the human P2Y1 receptor surface expression and activation processes.” J. Biol. Chem. 274, 14639-14647 (1999)

37. C. Sissi, S. Moro, A.P. Krapcho, E. Menta, M. Palumbo “Binding of 2-aza-antracenedione regioisomeres to DNA: effects of the relative position of the side-chain groups.” Anticancer-Drug Des. 14, 265-274 (1999)

36. S. Moro, C. Hoffmann, K.A. Jacobson “Role of the extracellular loops of G protein-coupled receptors in ligand recognition: a molecular modeling study of the human P2Y1 receptor.” Biochemistry 38, 3498-3507 (1999)

35. K.A. Jacobson, C. Hoffmann, Y.C. Kim, E. Camaioni, E. Nandanan, S.Y. Jang, D.P. Guo, X.D. Ji, I. Kugelgen, S. Moro “Molecular recognition in PB2B receptors: ligand development aided by molecular modeling and mutagenesis.” Prog. Brain Res. 120, 119-132 (1999)

34. A.H. Li, S. Moro, N. Forsyth, N. Melman, X.D. Ji, K.A. Jacobson “Synthesis, CoMFA analysys, and receptor docking of 3,5-diacyl-2,4-dislkylpyridine derivatives as selective AB3B adenosine receptor.” J. Med. Chem. 42, 706-721 (1999)

Back to content | Back to main menu